News Detail

Bengaluru, 16 March 2025: Indian pharmaceutical companies are aggressively expanding their US presence through a wave of acquisitions, likely as a hedge against future uncertainties. Leading players like Sun Pharma, Syngene, Senores, and Zydus have all made strategic purchases, r......
View Details
Source : The Hindu Businessline
India
pharma companies
regulations
Related News
- MIT engineers turn skin cells directly into neurons for cell therapy (17-03-2025)
- Police bust illegal sale of expired govt drugs in Kampala, 10 arrested (17-03-2025)
- Sun and Zydus Pharma pulling back some medications in the US due to quality issues (17-03-2025)
- Two Smugglers arrested with 11,520 Illegal Tablets (17-03-2025)
- Huge Stock of illegal cough syrups confiscated, two arrested (17-03-2025)
- Par panel suggests single independent drug controller for AYUSH (17-03-2025)
- Rise in pediatric pneumonia cases underscores the increasing issue of antibiotic resistance (16-03-2025)
- Extended use of steroids linked to risk of glaucoma, AIIMS docs caution (16-03-2025)
- WHO announces one batch of falsified Oxycontin 80mg identified in the WHO European Region (15-03-2025)
- Counterfeit medicine manufacturing units exist in states like UP, HP and Uttarakhand: Dinesh Gundu Rao in Assembly (15-03-2025)